Literature DB >> 6681041

Homologous radio-immunoassay of human plasma dopamine-beta-hydroxylase: analysis of homospecific activity, circulating plasma pool and intergroup differences based on race, blood pressure and cardiac function.

D T O'Connor, G L Levine, R P Frigon.   

Abstract

We used a homologous human dopamine-beta-hydroxylase (DBH) radio-immunoassay (RIA) to explore reported differences in plasma DBH enzymatic activity among patient groups stratified for race, blood pressure and cardiac function, as well as to determine plasma immunoreactive DBH protein pool and the relative activity of the enzyme in plasma versus human chromaffin tissue storage vesicles. Plasma DBH activity was lower in patients with congestive heart failure than in control subjects (19.9 +/- 4.0 versus 34.4 +/- 5.9 iu/l, P less than 0.05), paralleled by lower immunoreactive plasma DBH protein concentration (3.50 +/- 0.73 versus 6.34 +/- 1.05 micrograms/ml, P less than 0.05). All subject groups had similar plasma DBH homospecific activity (plasma DBH enzymatic activity/immunoreactive plasma DBH protein), ranging from 5.03 +/- 0.28 to 5.84 +/- 0.44 iu/mg. For the entire subject group, there was a significant relationship between plasma DBH activity and plasma DBH immunoreactive protein (r = 0.89, n = 78, P less than 0.01) from which no subgroup deviated systematically. Black hypertensives had lower plasma DBH activity than white hypertensives (23.0 +/- 5.2 versus 42.9 +/- 4.8 iu/l, P less than 0.01), though their plasma DBH homospecific activities and activity/immunoreactive protein plots were indistinguishable. Total circulating plasma DBH pools were large (from 13.1 +/- 3.7 to 27.5 +/- 4.8 mg).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681041     DOI: 10.1097/00004872-198310000-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  11 in total

1.  The catecholamine biosynthetic enzyme dopamine β-hydroxylase (DBH): first genome-wide search positions trait-determining variants acting additively in the proximal promoter.

Authors:  Maja Mustapic; Adam X Maihofer; Manjula Mahata; Yuqing Chen; Dewleen G Baker; Daniel T O'Connor; Caroline M Nievergelt
Journal:  Hum Mol Genet       Date:  2014-06-30       Impact factor: 6.150

2.  Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure.

Authors:  Yuqing Chen; Kuixing Zhang; Gen Wen; Fangwen Rao; Amber P Sanchez; Lei Wang; Juan L Rodriguez-Flores; Manjula Mahata; Sushil K Mahata; Jill Waalen; Michael G Ziegler; Bruce A Hamilton; Daniel T O'Connor
Journal:  Am J Hypertens       Date:  2010-09-02       Impact factor: 2.689

3.  Pharmacogenetics of Dopamine β-Hydroxylase in cocaine dependence therapy with doxazosin.

Authors:  Xuefeng Zhang; David A Nielsen; Coreen B Domingo; Daryl I Shorter; Ellen M Nielsen; Thomas R Kosten
Journal:  Addict Biol       Date:  2018-03-02       Impact factor: 4.280

4.  Association between polymorphisms of the DBH and DAT1 genes and attention deficit hyperactivity disorder in children from Jordan.

Authors:  Mohammad Y Gharaibeh; Sajida Batayneh; Omar F Khabour; Azhar Daoud
Journal:  Exp Ther Med       Date:  2010-07-01       Impact factor: 2.447

Review 5.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

6.  Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure.

Authors:  Yuqing Chen; Gen Wen; Fangwen Rao; Kuixing Zhang; Lei Wang; Juan L Rodriguez-Flores; Amber P Sanchez; Manjula Mahata; Laurent Taupenot; Ping Sun; Sushil K Mahata; Bamidele Tayo; Nicholas J Schork; Michael G Ziegler; Bruce A Hamilton; Daniel T O'Connor
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

7.  A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders.

Authors:  C Hess; A Reif; A Strobel; A Boreatti-Hümmer; M Heine; K-P Lesch; C P Jacob
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

8.  Chromogranin A in children with neuroblastoma. Serum concentration parallels disease stage and predicts survival.

Authors:  R J Hsiao; R C Seeger; A L Yu; D T O'Connor
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

9.  Dopamine beta hydroxylase genotype identifies individuals less susceptible to bias in computer-assisted decision making.

Authors:  Raja Parasuraman; Ewart de Visser; Ming-Kuan Lin; Pamela M Greenwood
Journal:  PLoS One       Date:  2012-06-27       Impact factor: 3.240

10.  Heritable influence of DBH on adrenergic and renal function: twin and disease studies.

Authors:  Dalal N Pasha; Jason T Davis; Fangwen Rao; Yuqing Chen; Gen Wen; Maple M Fung; Manjula Mahata; Kuixing Zhang; Danuta Trzebinska; Maja Mustapic; C Makena Hightower; Michael S Lipkowitz; Ming Ji; Michael G Ziegler; Caroline M Nievergelt; Daniel T O'Connor
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.